RPID

Rapid Micro Biosystems Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 4/10
  • Value↓ 0/10
Rapid Micro Biosystems sales and earnings growth
RPID Growth
Neutral
  • Revenue Y/Y↑ 19.74%
  • EPS Y/Y↓ 2.78%
  • FCF Y/Y↑ 29.89%
Rapid Micro Biosystems gross and profit margin trends
RPID Profitability
Neutral
  • Gross margin ↓ 3.10%
  • EPS margin↓ -140.30%
  • ROIC 5Y↓ 0.00%
Rapid Micro Biosystems net debt vs free cash flow
RPID Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 0.1
  • Interest coverage↓ -42.2

Rapid Micro Biosystems stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗